20/20 Biolabs, Inc. Common Stock (AIDX) Investor Relations Documents

20/20 Biolabs, Inc. Common Stock (AIDX) investor relations documents from the company's IR site: 3 presentations, 8 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.

08/05/2026 Monthly Investor Webinar Series #2 Webcast Replay: Presentation: Click Here: AIDX investor webinar detailing the 2028 Medicare reimbursement pathway for Multi-Cancer Early Detection (MCED) tests and the strategic positioning of OneTest.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-28	Press release	20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue an
2026-08-26	Press release	20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportu
2026-08-17	Press release	20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reac
2026-08-05	Presentation	08/05/2026 Monthly Investor Webinar Series #2 Webcast Replay: Presentation: Click Here
2026-07-30	Press release	20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management's Rec
2026-07-01	Presentation	Time: 12:00 p.m. ET Webcast Replay: Presentation: Click Here
2026-05-20	Press release	20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
2026-05-14	Press release	20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
2026-04-20	Presentation	Investor Presentation
2026-03-31	Press release	20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
2026-02-20	Press release	20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time

AIDX overview · AIDX earnings · AIDX financials · AIDX KPIs · AIDX documents · AIDX ownership · AIDX peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.